Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors

A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS

J.T. LITCHFIELD, Frank Wilcoxon · Journal of Pharmacology and Experimental Therapeutics · 1949 · 7.3K citations

Public Health, Biostatistics, Pharmacology +12

Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor

Jennifer L. Stamos, Mark X. Sliwkowski, Charles Eigenbrot · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines

Jeffrey A. Engelman, Pasi A. Jänne, Craig H. Mermel et al. · Proceedings of the National Academy of Sciences · 2005 · 489 citations · Full text

Medicine, Oncology, Pharmacology +15

Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation

Mayumi Ono, Akira Hirata, Takuro Kometani et al. · Molecular Cancer Therapeutics · 2004 · 309 citations · Full text

Medicine, Oncology, Pharmacology +17

Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents

Ying‐Chao Duan, Yong‐Cheng Ma, En Zhang et al. · European Journal of Medicinal Chemistry · 2013 · 263 citations

Pharmacy, Medicinal Chemistry, Oncology +12